BNP Paribas Financial Markets
RPTP

BNP Paribas Financial Markets’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

BNP Paribas Financial Markets’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,953
Closed -$53.4K – 4295
2016
Q3 		$53.4K Buy
5,953
+2,596
+77% +$18.5K ﹤0.01% 2407
2016
Q2 		$18K Buy
3,357
+3,336
+15,886% +$17.1K ﹤0.01% 2627
2016
Q1 		$97 Sell
21
-17,979
-100% -$72.3K ﹤0.01% 2622
2015
Q4 		$93.6K Sell
18,000
-46,991
-72% -$273K ﹤0.01% 2376
2015
Q3 		$393K Sell
64,991
-98,465
-60% -$1.21M ﹤0.01% 1496
2015
Q2 		$2.58M Buy
163,456
+161,977
+10,952% +$1.97M 0.01% 775
2015
Q1 		$16.1K Buy
+1,479
New +$15.1K ﹤0.01% 2475
2014
Q4 		– Sell
-3,855
Closed -$37K – 4199
2014
Q3 		$37K Buy
+3,855
New +$39.4K ﹤0.01% 2783
2014
Q1 		– Sell
-773
Closed -$10.1K – 4292
2013
Q4 		$10.1K Sell
773
-14,822
-95% -$204K ﹤0.01% 2634
2013
Q3 		$233K Sell
15,595
-3,851
-20% -$46.1K ﹤0.01% 2126
2013
Q2 		$182K Buy
+19,446
New +$132K ﹤0.01% 2373

BNP Paribas Financial Markets's RPTP Position: Q4 2016 in Review

BNP Paribas Financial Markets sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 5,953 shares — an estimated $53.4K sold.

BNP Paribas Financial Markets first reported a position in RPTP in Q2 2013 and held it in 11 quarters. The position peaked at $2.58M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • BNP Paribas Financial Markets reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,953 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $53.4K.
  • BNP Paribas Financial Markets first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 11 quarters.
  • BNP Paribas Financial Markets's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.58M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2016, filed 14 Feb 2017.